A detailed history of Quest Partners LLC transactions in Xencor Inc stock. As of the latest transaction made, Quest Partners LLC holds 7,264 shares of XNCR stock, worth $108,451. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,264
Previous 12,946 43.89%
Holding current value
$108,451
Previous $102 Million 16.26%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

SELL
$7.0 - $11.73 $39,774 - $66,649
-5,682 Reduced 43.89%
7,264 $85.2 Million
Q2 2025

Jul 31, 2025

BUY
$7.52 - $11.26 $57,460 - $86,037
7,641 Added 144.03%
12,946 $102 Million
Q1 2025

May 14, 2025

BUY
$10.64 - $24.13 $56,445 - $128,009
5,305 New
5,305 $56.4 Million
Q2 2024

Aug 06, 2024

BUY
$18.21 - $24.5 $185,996 - $250,243
10,214 Added 121.23%
18,639 $353 Million
Q1 2024

May 09, 2024

BUY
$18.65 - $26.52 $103,749 - $147,530
5,563 Added 194.37%
8,425 $186 Million
Q4 2023

Feb 09, 2024

BUY
$16.53 - $21.42 $47,308 - $61,304
2,862 New
2,862 $60.8 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $891M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.